MicroRNA Involvement in the Onset and Progression of Barrett's Esophagus: a Systematic Review

Overview

Journal Oncotarget

Specialty Oncology

Date 2018 Mar 1

PMID 29487725

Citations 17

Authors

Reilly J Clark

Michael P Craig

Sangeeta Agrawal

Madhavi Kadakia

Affiliations

Soon will be listed here.

Abstract

Esophageal adenocarcinoma (EAC) is a highly aggressive malignancy that develops from Barrett's esophagus (BE), an intestinal metaplasia of the distal esophagus. microRNAs (miRNAs), short non-coding regulatory RNAs, are frequently dysregulated in BE and are thought to play key roles in the onset of BE and its progression to EAC. miRNAs thus have potential diagnostic and prognostic value and are increasingly being used as cancer biomarkers. This review summarizes the current literature related to miRNAs that are dysregulated in BE within the context of Hedgehog, Notch, MAPK, NF kappa-B, Wnt and epithelial-mesenchymal transition (EMT) signaling which are thought to drive BE onset and progression. This comprehensive analysis of miRNAs and their associated signaling in the regulation of BE provides an overview of vital discoveries in this field and highlights gaps in our understanding of BE pathophysiology that warrant further investigation.

Citing Articles

New Techniques to Screen for Barrett Esophagus.

Strauss A, Falk G Gastroenterol Hepatol (N Y). 2023; 19(7):383-390.

PMID: 37771620 PMC: 10524417.

Expanding beyond endoscopy: A review of non-invasive modalities in Barrett's esophagus screening and surveillance.

Shahsavari D, Kudaravalli P, Yap J, Vega K World J Gastroenterol. 2022; 28(32):4516-4526.

PMID: 36157931 PMC: 9476875. DOI: 10.3748/wjg.v28.i32.4516.

Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction.

Sugano K, Spechler S, El-Omar E, McColl K, Takubo K, Gotoda T Gut. 2022; 71(8):1488-1514.

PMID: 35725291 PMC: 9279854. DOI: 10.1136/gutjnl-2022-327281.

Comprehensive RNA dataset of tissue and plasma from patients with esophageal cancer or precursor lesions.

Schoofs K, Philippron A, Avila Cobos F, Koster J, Lefever S, Anckaert J Sci Data. 2022; 9(1):86.

PMID: 35288573 PMC: 8921197. DOI: 10.1038/s41597-022-01176-x.

Computational pathology aids derivation of microRNA biomarker signals from Cytosponge samples.

Masque-Soler N, Gehrung M, Kosmidou C, Li X, Diwan I, Rafferty C EBioMedicine. 2022; 76:103814.

PMID: 35051729 PMC: 8883000. DOI: 10.1016/j.ebiom.2022.103814.

References

Hormi-Carver K, Zhang X, Zhang H, Whitehead R, Terada L, Spechler S . Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway. Cancer Res. 2009; 69(2):672-7. PMC: 2629390. DOI: 10.1158/0008-5472.CAN-08-3703. View

Fan D, Ren B, Yang X, Liu J, Zhang Z . Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer. J Exp Clin Cancer Res. 2016; 35(1):177. PMC: 5111270. DOI: 10.1186/s13046-016-0432-x. View

Xie J, Chen M, Zhou J, Mo M, Zhu L, Liu Y . miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression. Oncol Rep. 2014; 31(4):1715-22. DOI: 10.3892/or.2014.3052. View

Zavadil J, Ye H, Liu Z, Wu J, Lee P, Hernando E . Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas. PLoS One. 2010; 5(8):e12362. PMC: 2927438. DOI: 10.1371/journal.pone.0012362. View

Song S, Byrd J, Guha S, Liu K, Koul D, Bresalier R . Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway. Cancer. 2013; 117(11):2386-97. PMC: 3116027. DOI: 10.1002/cncr.25796. View

Sicard F, Gayral M, Lulka H, Buscail L, Cordelier P . Targeting miR-21 for the therapy of pancreatic cancer. Mol Ther. 2013; 21(5):986-94. PMC: 3666633. DOI: 10.1038/mt.2013.35. View

Wijnhoven B, Hussey D, Watson D, Tsykin A, Smith C, Z Michael M . MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg. 2010; 97(6):853-61. DOI: 10.1002/bjs.7000. View

Wang Y, Mao G, Lv Y, Huang Q, Wang G . MicroRNA-181b stimulates inflammation via the nuclear factor-κB signaling pathway . Exp Ther Med. 2015; 10(4):1584-1590. PMC: 4578103. DOI: 10.3892/etm.2015.2702. View

Goldman A, Chen H, Roesly H, Hill K, Tome M, Dvorak B . Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis. Am J Physiol Gastrointest Liver Physiol. 2010; 300(2):G292-302. PMC: 3043651. DOI: 10.1152/ajpgi.00461.2010. View

10.

Taddei A, Fabbroni V, Pini A, Lucarini L, Ringressi M, Fantappie O . Cyclooxygenase-2 and inflammation mediators have a crucial role in reflux-related esophageal histological changes and Barrett's esophagus. Dig Dis Sci. 2013; 59(5):949-57. DOI: 10.1007/s10620-013-2975-4. View

11.

Sreedharan L, Mayne G, Watson D, Bright T, Lord R, Ansar A . MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus. World J Gastroenterol. 2017; 23(30):5508-5518. PMC: 5558114. DOI: 10.3748/wjg.v23.i30.5508. View

12.

van Baal J, Diks S, Wanders R, Rygiel A, Milano F, Joore J . Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardia. Cancer Res. 2006; 66(24):11605-12. DOI: 10.1158/0008-5472.CAN-06-1370. View

13.

Bus P, Kestens C, Ten Kate F, Peters W, Drenth J, Roodhart J . Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol. 2015; 51(6):560-70. PMC: 4880635. DOI: 10.1007/s00535-015-1133-5. View

14.

Leidner R, Ravi L, Leahy P, Chen Y, Bednarchik B, Streppel M . The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. Genes Chromosomes Cancer. 2012; 51(5):473-9. PMC: 3547654. DOI: 10.1002/gcc.21934. View

15.

Bansal A, Fitzgerald R . Biomarkers in Barrett's Esophagus: Role in Diagnosis, Risk Stratification, and Prediction of Response to Therapy. Gastroenterol Clin North Am. 2015; 44(2):373-90. DOI: 10.1016/j.gtc.2015.02.008. View

16.

Kappelmann M, Kuphal S, Meister G, Vardimon L, Bosserhoff A . MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. Oncogene. 2012; 32(24):2984-91. DOI: 10.1038/onc.2012.307. View

17.

Bansal A, Gupta V, Wang K . MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus. J Cell Biochem. 2016; 117(6):1288-95. DOI: 10.1002/jcb.25497. View

18.

Phillips R, Frierson Jr H, Moskaluk C . Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol. 2003; 27(11):1442-7. DOI: 10.1097/00000478-200311000-00006. View

19.

Slaby O, Srovnal J, Radova L, Gregar J, Juracek J, Luzna P . Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma. Carcinogenesis. 2015; 36(5):521-7. DOI: 10.1093/carcin/bgv023. View

20.

Burnat G, Rau T, Elshimi E, Hahn E, Konturek P . Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line. Scand J Gastroenterol. 2007; 42(12):1460-5. DOI: 10.1080/00365520701452209. View